Latest Capital Management Strategies News

Page 19 of 29
Gibb River Diamonds has secured a contract mining agreement for its Edjudina Gold Project, aiming to start open pit mining at the Neta Prospect by August 2025, subject to permit approvals. The deal minimizes financial risk while positioning the company to capitalise on gold production.
Maxwell Dee
Maxwell Dee
31 July 2025
Oakajee Corporation has progressed its gold exploration efforts at the Paynes Find project in Western Australia, preparing for drilling in the September quarter while maintaining a solid financial position.
Maxwell Dee
Maxwell Dee
31 July 2025
Larvotto Resources has given the final nod to develop its Hillgrove Antimony-Gold Project in NSW, fully funded and moving into construction with production set for mid-2026.
Maxwell Dee
Maxwell Dee
31 July 2025
Garda Property Group’s FY25 results reveal a strategic pivot with significant asset sales and a sharp reduction in gearing, setting the stage for an 11% rise in distributions in FY26.
Eva Park
Eva Park
30 July 2025
Bubalus Resources has completed maiden drilling at its Bubalus South gold-antimony project and is gearing up for further drilling at Crosbie North and Avon Plains, supported by a strong cash position of AUD 3.25 million.
Maxwell Dee
Maxwell Dee
28 July 2025
Volt Group Limited (ASX – VPR) has initiated an on-market share buy-back of up to 5% of its issued capital, aligning with its capital management strategy as it advances commercialisation of its innovative zero-emission technologies.
Victor Sage
Victor Sage
28 July 2025
Korvest Ltd has announced a fully franked dividend of AUD 0.50 per share, combining ordinary and special dividends, with payment scheduled for early September.
Victor Sage
Victor Sage
25 July 2025
Newmont Corporation reported a robust second quarter in 2025, highlighted by record free cash flow and a fresh $3 billion share repurchase program, while reaffirming its full-year guidance.
Maxwell Dee
Maxwell Dee
25 July 2025
Race Oncology has safely treated the first patient with its RC220 drug alone and in combination with doxorubicin in a Phase 1 trial, while bolstering its clinical leadership and maintaining a strong cash position to fund operations through 2026.
Ada Torres
Ada Torres
23 July 2025
Euroz Hartleys Group Limited has secured shareholder approval for a $63 million capital return, marking a significant milestone in its long history of shareholder distributions.
Claire Turing
Claire Turing
18 July 2025
Ironbark Capital Limited has announced an on-market buy-back of up to 10.46 million ordinary shares, commencing July 21, 2025, and running through to July 2026. This move signals a strategic capital management initiative without requiring shareholder approval.
Victor Sage
Victor Sage
18 July 2025
Rapid Critical Metals has completed its capital consolidation and placement, reshaping its issued capital structure with shareholder approval.
Maxwell Dee
Maxwell Dee
16 July 2025